维替泊芬对间质液流诱导人Tenon囊成纤维细胞纤维化转分化的影响
本研究在二维和三维体外模型中探讨机械敏感YAP/TAZ通路在液流诱导人Tenon囊成纤维细胞纤维化中的作用,并测试维替泊芬的抑制效果。结果显示慢速液流增加YAP/TAZ染色强度,维替泊芬在二维模型中轻度减少液流诱导的纤维化改变,在三维模型中显著抑制COL1A1、CTGF和FN1表达。作者认为YAP/TAZ抑制可能通过抑制机械刺激诱导的纤维化改变而在青光眼滤过术后具有治疗潜力。
要点
- 慢速间质液流可激活人Tenon囊成纤维细胞中的YAP/TAZ通路。
- 维替泊芬在二维模型中轻度减少液流诱导的纤维化改变。
- 维替泊芬在三维模型中显著抑制液流诱导的COL1A1、CTGF和FN1表达升高。
核心结论
- 慢速间质液流激活YAP/TAZ通路。
- 维替泊芬通过减少形态学改变和抑制液流诱导的ECM基因表达发挥抗纤维化潜力。
- 作者认为YAP/TAZ抑制可能通过抑制机械刺激诱导的纤维化改变而在青光眼滤过术后具有治疗潜力。
研究设计与样本
- 体外研究:人Tenon囊成纤维细胞在二维和三维模型中暴露于连续液流48或72小时,并设或不设YAP/TAZ转录增强关联结构域抑制剂维替泊芬。
- 二维模型采用共聚焦免疫荧光显微镜观察F-actin细胞骨架、纤连蛋白1(FN1)、YAP和TAZ。
- 三维模型提取mRNA,采用定量PCR检测纤维化相关基因表达。
主要发现
- 暴露于慢速液流的人Tenon囊成纤维细胞显示YAP/TAZ染色强度增加。
- 维替泊芬在二维模型中轻度减少液流诱导的纤维化改变。
- 三维模型中,维替泊芬显著抑制液流诱导的细胞外基质基因COL1A1、CTGF和FN1表达升高。
临床怎么用
- 作者认为YAP/TAZ抑制可能通过抑制机械刺激诱导的纤维化改变而在青光眼滤过术后具有治疗潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Postoperative scarring remains the major challenge in achieving long-term success after glaucoma filtration surgery. In a previous study, we showed that slow continuous fluid flow is sufficient to induce fibrotic responses in human tenon fibroblasts (HTFs) in two-dimensional (2D) and three-dimensional (3D) in vitro models. In the present study, we investigated the role of the mechanosensitive Yes-associated protein (YAP) and transcriptional coactivator (TAZ) signaling pathway in flow-induced fibrosis. METHODS: HTFs were exposed to continuous fluid flow for 48 or 72 hours in the presence or absence of the YAP/TAZ-transcriptional enhanced associated domain inhibitor verteporfin (VP). In a 2D model, the F-actin cytoskeleton, fibronectin 1 (FN1), YAP, and TAZ were visualized by confocal immunofluorescence microscopy. In a 3D model, mRNA was extracted, and the expression of fibrosis-associated genes was detected by quantitative PCR. RESULTS: HTFs exposed to slow fluid flow showed increased staining intensities for YAP/TAZ. Inhibition of YAP/TAZ by VP slightly reduced flow-induced fibrotic changes in the 2D model. The flow-induced increase in the expression of the extracellular matrix (ECM) genes COL1A1, CTGF, and FN1 was significantly inhibited by VP in the 3D model. CONCLUSIONS: Slow interstitial fluid flow activates the YAP/TAZ pathway. VP exerts antifibrotic potential by reducing morphologic changes and suppressing the expression of ECM genes induced by flow. Therefore, YAP/TAZ inhibition may exhibit therapeutic potential after glaucoma filtration surgery by inhibiting fibrotic changes induced by mechanical stimuli.
引用
- Frömmichen J, Bungert E, Ströble J, et al. Effects of Verteporfin on Interstitial Fluid Flow-Induced Fibrotic Transdifferentiation of Human Tenon Fibroblasts. Invest Ophthalmol Vis Sci. 2025. PMID: 40197780. doi:10.1167/iovs.66.4.17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。